PPARγ: The Central Mucus Barrier Coordinator in Ulcerative Colitis

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• Ulcerative colitis (UC) is a chronic inflammatory colon disorder with a relapsing-remitting course.
• The intestinal mucus barrier protects against microbial invasion and its impairment correlates with UC severity.
• Mucus barrier depletion is the sole independent predictor of UC relapse.

Purpose of the Study:

• To investigate the role of Peroxisome proliferator-activated receptor gamma (PPARγ) in ulcerative colitis.
• To explore PPARγ's potential as a therapeutic target for UC by examining its effects on the mucus barrier and host-microbiota interactions.

Main Methods:

• Review of existing patient and animal study data.
• Analysis of PPARγ's known functions in inflammation, mucus secretion, and host-microbiota interactions.
• Exploration of PPARγ's influence on colonocyte metabolism and intestinal oxygen availability.

Main Results:

• PPARγ regulates inflammatory cytokine expression and promotes mucus secretion.
• PPARγ influences host-microbiota interactions by modulating colonocyte energy metabolism and gut oxygen levels.
• Gut microbiota homeostasis, crucial for butyrate production, is linked to colonocyte energy.

Conclusions:

• PPARγ plays a central role in coordinating the intestinal mucus barrier.
• PPARγ modulation presents a potential therapeutic strategy for ulcerative colitis.